Ocrevus (ocrelizumab) is a monoclonal antibody used to treat multiple sclerosis (MS), including both relapsing and primary progressive forms. It works by targeting CD20-positive B cells, which are believed to play a role in the disease’s progression. Ocrevus has been approved for use in India and is available through Medlama. For detailed information on Ocrevus price in India and patient assistance programs, please visit our website.
Ads Blocker Detected!!!
We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.
